Asia-Pacific Negative Pressure Wound Therapy Devices Market is expected to reach USD 1,074.5 million by 2024 from USD 493.9 million in 2016, at a CAGR of 9.8% in the forecast period 2017 to 2024.
The major factors driving the growth of this market are rising aging and geriatric population and technological advancement in negative pressure wound therapy devices increased number of surgical procedures, government support for promoting negative pressure wound therapy rising incidence of diabetes. On the other hand, high cost of products and availability of substitute products hinders the market growth.
The key market players for Asia-Pacific Negative Pressure Wound Therapy Devices Market are listed below;
Acelity L.P. Inc.
Smith & Nephew
M?lnlycke Health Care AB.
The market is further segmented into;
Product type
wound type
End user
Distribution channel
Geography
The Asia-Pacific Negative Pressure Wound Therapy Devices market is segmented on the basis of product type, wound type, end user and distribution channel. On the basis of product type, the Asia-Pacific negative pressure wound therapy devices market is segmented into stand-alone negative-pressure wound therapy devices, portable negative-pressure wound therapy devices and disposable negative-pressure wound therapy devices. In 2017, standalone negative pressure wound therapy devices segment is expected to dominate the Asia-Pacific negative pressure wound therapy devices market with 56.8% market share and is expected to reach USD 524.6 million by 2024, growing with a CAGR of 7.4% in the forecast period 2017 to 2024.
On the basis of wound type, the Asia-Pacific negative pressure wound therapy devices market is segmented into surgical wound, diabetic ulcers, burns, pressure ulcers, venous ulcers and others. In 2017, surgical wound is expected to dominate the Asia-Pacific negative pressure wound therapy devices market with 31.4% market share and is expected to reach USD 302.2 million by 2024, growing with a CAGR of 8.0% in the forecast period 2017 to 2024.
On the basis of end-user, the Asia-Pacific negative pressure wound therapy devices market is segmented into hospitals, wound care centres, ambulatory centres, home healthcare, clinics and community healthcare. In 2017, hospital is expected to dominate the Asia-Pacific negative pressure wound therapy devices market with 45.3% market share and is expected to reach USD 372.8 million by 2024, growing with a CAGR of 5.7% in the forecast period 2017 to 2024.
On the basis of distribution channel, the Asia-Pacific negative pressure wound therapy devices market is segmented into direct tenders and distributor & retails. In 2017, direct tenders is expected to dominate the Asia-Pacific negative pressure wound therapy devices market with 77.3% market share and is expected to reach USD 876.9 million by 2024, growing with the highest CAGR of 10.6% in the forecast period 2017 to 2024.
Based on geography, the Asia-Pacific Negative pressure wound therapy devices market is segmented into geographical regions, such as,
China,
Japan,
India,
South Korea,
Australia,
Thailand,
Malaysia,
Singapore,
Indonesia,
Philippines
Rest of Asia-Pacific
Covered in this report
The report covers the present scenario and the growth prospects of the Asia-Pacific Negative pressure wound therapy devices market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst?s time when you purchase this market report. Details are provided within the report.
